HEALTH

SDI: Many Americans have received seasonal flu shot

BY Michael Johnsen

PLYMOUTH MEETING, Pa. More than 690,000 Americans already have received this season’s flu vaccine from their doctors, according to SDI’s VaccineTrack data through Sept. 4.

 

VaccineTrack provides syndicated weekly vaccine usage by physicians based on medical office electronic healthcare reimbursement claims data.

 

 

The Centers for Disease Control and Prevention recently announced an unprecedented campaign to combat seasonal flu through a universal vaccination strategy. CDC removed many restrictions and currently supports seasonal influenza vaccination for all persons 6 months of age and older based on the recommendation of the Advisory Committee on Immunization Practices, which advises CDC on vaccine issues.

 

 

In the 2010-2011 season, vaccine manufacturers are slated to produce more influenza vaccine than ever before. Shipments of influenza vaccine began weeks ahead of most other seasons in anticipation of rapid and wide-ranging vaccine uptake.

 

 

“These measures taken by the CDC and vaccine manufacturers facilitate public health efforts to make flu vaccines available to all,” stated Andrew Kress, CEO of SDI.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Watson gets FDA approval for generic Yasmin

BY Alaric DeArment

MORRISTOWN, N.J. The Food and Drug Administration has approved a generic oral contraceptive made by Watson Pharmaceuticals, the drug maker said Tuesday.

 

Watson announced the FDA’s approval of Zarah (drospirenone and ethinyl estradiol tablets) in the 3 mg/0.03 mg strength. The drug is a generic version of Bayer’s Yasmin.

 

 

Watson said it has started shipping the drug, though Bayer’s patent litigation suit against the company concerning the drug remains pending in the U.S. District Court for the Southern District of New York.

 

 

Yasmin and generic versions had sales of around $97 million during the 12 months ended in June, according to IMS Health.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

HEALTH

Periscope thinks pink with new lighted folio

BY Allison Cerra

RIDGEWOOD, N.J. A maker of deluxe e-reader covers has released a new version of its lighted folio.

Periscope released its new pink lighted folio in line with National Breast Cancer Awareness Month, the company said. Available for a suggested retail price of $49.95, the Periscope lighted folio is an “all-in-one” item that features a retractable Periscope twin LED reading light, deluxe cover and notebook/pen holder in one fashionably designed pink leatherette unit.

“With today’s debut of the pink lighted folio for both the [Amazon] Kindle 2 and [Barnes & Noble] Nook e-readers, and with National Breast Cancer Awareness Month occurring in October, we decided there was no better time to show our support of those whose lives have been affected by breast cancer,” Periscope president Eric Fisherman said. “The new pink lighted folio makes an ideal gift choice for gift-givers who wish to give a gift that has a greater significance. Now every time a consumer uses their pink lighted folio, they will be reminded of all those whose lives have been touched in any way by breast cancer.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES